BASF introduces new solutions for the personal care market15 Nov 2018
Wax-based and readily biodegradable: Euperlan OP White and Cegesoft Peel.
At SCS Formulate on 13 & 14 November in Coventry, BASF will share stand 500 with its European distribution organization BTC Europe and present the latest solutions to meet the demands of the personal care market.
Readily biodegradable, wax-based opacifier dispersion and exfoliating beads for personal care products
BASF Care Creations will showcase two new products that answer the needs of today’s environmentally conscious consumers. “We are constantly seeking innovative and more sustainable solutions for the personal care industry. Consumer trends and needs clearly show us the way. With our new ingredients Euperlan OP White and Cegesoft Peel we can help our customers to develop winning products supporting both the consumers’ well-being and eco-conscience,” said Dirk Mampe, Vice President Business Management Personal Care Solutions Europe.
Euperlan OP White is a wax-based, readily biodegradable and cold processable opacifier dispersion with a superior white appearance for surfactant formulations. The product meets today’s demand for ecological friendly ingredients and its unique properties make it particularly suitable for eco-label conforming skin and hair cleansing formulations. BASF is the leading supplier of cold processable wax dispersions for personal care that provide optical effects in rinse off products. Euperlan OP White complements BASF’s current portfolio of pearlizing wax dispersions and can be used as an alternative to synthetic polymeric opacifiers.
Cegesoft Peel consists of round wax beads that provide a gentle and mild exfoliation. Mainly derived from natural and renewable resources, Cegesoft Peel is a readily biodegradable and environmentally friendly alternative to sharp-edged abrasives and non-degradable beads (often referred to as microplastic beads).
Hyalurosmooth – counteracting harmful effects of daily stress
Daily stresses are known to translate into cutaneous stress, with cortisol as its main mediator. Hyalurosmooth represses the damaging impact of cortisol on the skin, restoring collagen type I and hyaluronic acid that are affected. Bringing the positive effects of a mindful lifestyle – rested from the inside – Hyalurosmooth helps the skin recover its hydration and radiance. Extracted from the Indian Cassia angustifolia, Hyalurosmooth is IECIC-listed.
As part of the Inspire presentation program, Axel Boettcher from BTC Europe will be presenting new data on Hyalurosmooth.
Chemspace and LabNetwork collaborate to extend access to chemical databases
14 Feb 2019
Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds.Read more
SGS to conduct its first malaria human challenge trial in Belgium
13 Feb 2019
The advanced candidate compound undergoing the trial has demonstrated potential to target malaria parasites before they have a chance to establish the symptoms of malaria.Read more
Post-EU FMD deadline - 'business as usual'?
12 Feb 2019
Partner connectivity will be an immediate and ongoing challenge beyond the deadline and several pharma companies are likely to break agreements with current suppliers through breach of contract clauses.Read more
BASF opens Application Technology Laboratory for personal care in Nigeria
11 Feb 2019
Local competence in application and formulation technology for sub-Saharan African personal care market.Read more
FDA approves first Nanobody-based medicine for adults with aTTP
10 Feb 2019
Cablivi is the first US approval for Sanofi's new rare blood disorders franchise.Read more
Pharmapack Europe 2019 Award Winners
7 Feb 2019
Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.Read more
Brexit - the EU FMD's painful problem
7 Feb 2019
Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.Read more
New series of advanced freeze dryers
6 Feb 2019
The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.Read more
Hitachi Chemical to acquire apceth Biopharma
5 Feb 2019
Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.Read more
FDA approves first generic Advair Diskus
4 Feb 2019
Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation